Autolus Therapeutics (AUTL) Net Margin (2017 - 2026)
Autolus Therapeutics' Net Margin was -85.60% in Q2 2026, up 143.41 percentage points from -229.02% a year earlier.
Powered by 
Analysis
Autolus Therapeutics (AUTL) Net Margin (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Autolus Therapeutics' Net Margin was -228.80% through Jun 30, 2026, up 532.13 percentage points year-over-year; for FY2025, it was -381.40%, up 1799.43 percentage points from FY2024.
- Net Margin shows a five-year change of +7904.32 percentage points (FY2020 to FY2025).
- In earlier years, Net Margin was -2180.83% in FY2024 (+10092.43 pp), -12273.26% in FY2023 (-9933.03 pp), -2340.24% in FY2022 (+3758.30 pp) and -6098.54% in FY2021 (+2187.17 pp).
- The Q2 2026 figure marks the highest quarterly Net Margin in data going back to Q1 2018.
- The best year-over-year quarter for Net Margin over five years was Q4 2025 (a gain of 94800.53 percentage points); the worst was Q3 2021 (a drop of 10166.44 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 32.99% |
| 10 | Autolus Therapeutics | 660.38 Mn | -663.71 Mn | 25.22 Mn | -85.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -85.60% |
| Dec 31, 2025 | -371.89% |
| Sep 30, 2025 | -373.30% |
| Jun 30, 2025 | -229.02% |
| Mar 31, 2025 | -781.13% |
| Dec 31, 2024 | -95,172.41% |
| Mar 31, 2024 | -522.15% |
| Sep 30, 2023 | -11,292.86% |
| Mar 31, 2023 | -3,081.35% |
| Dec 31, 2022 | -704.29% |
| Sep 30, 2022 | -1,805.28% |
| Mar 31, 2022 | -22,326.51% |
| Dec 31, 2021 | -23,147.78% |
| Sep 30, 2021 | -14,406.78% |
| Jun 30, 2021 | -2,018.24% |
| Mar 31, 2021 | -12,366.54% |
| Dec 31, 2020 | -21,013.24% |
| Sep 30, 2020 | -4,240.34% |
| Jun 30, 2020 | -10,936.86% |
| Mar 31, 2020 | -8,838.17% |
API Access
Autolus Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();